FDA Breakthrough Therapy Designation-Trial Design and More - Commentary
Clin Pharmacol Ther
.
2021 Oct;110(4):869-870.
doi: 10.1002/cpt.2378.
Epub 2021 Aug 14.
Authors
Jacqueline Corrigan-Curay
1
,
Peter Stein
1
Affiliation
1
Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
PMID:
34389983
DOI:
10.1002/cpt.2378
No abstract available
Publication types
Comment
MeSH terms
Drug Approval*
Humans
United States
United States Food and Drug Administration